Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
联合阻断激活 ERBB2 突变和 ER 可导致 ER+/HER2 突变乳腺癌的综合致死率
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-1544
Sarah Croessmann, Luigi Formisano, Lisa N Kinch, Paula I Gonzalez-Ericsson, Dhivya R Sudhan, Rebecca J Nagy, Aju Mathew, Eric H Bernicker, Massimo Cristofanilli, Jie He, Richard E Cutler Jr, Alshad S Lalani, Vincent A Miller, Richard B Lanman, Nick V Grishin, Carlos L Arteaga4